Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial)
Trial NL7539 at 'Overview of Medical Research in the Netherlands' (ID NL-OMON21471). Date of registration 19-02-2019.
Authors
- Daan van de Kerkhof (ORCID: https://orcid.org/0000-0002-0126-4695)
- Jan Gerard Maring (ORCID: https://orcid.org/0009-0009-8533-9233)
- Geert-Jan Creemers (ORCID: https://orcid.org/0000-0002-9358-1996)
- B.J.C. van den Bosch (ORCID: https://orcid.org/0000-0002-4067-6203)
- Maarten A. Hanrath
- Sebastian A. H. van den Wildenberg (ORCID: https://orcid.org/0000-0002-1011-842X)
- Dirk Jan A. R. Moes (ORCID: https://orcid.org/0000-0003-3219-253X)
- Ramon Bax
- Pierre M. Bet (ORCID: https://orcid.org/0000-0001-6735-7379)
- M. Boisdron‐Celle
- Maarten J. Deenen (ORCID: https://orcid.org/0000-0002-4389-6420)
- Evi Banken (ORCID: https://orcid.org/0009-0002-6684-0101)
- I E G van Hellemond
Institutions
- Radboud University Nijmegen (NL)
- Inserm (FR)
- Leiden University Medical Center (NL)
- Catharina Ziekenhuis (NL)
- Maastricht University (NL)
- Isala (NL)
- Eindhoven University of Technology (NL)
Publication Details
- Journal
- Cancer Chemotherapy and Pharmacology
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1007/s00280-025-04759-8
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00